India to be vaccinated against Covid-19 in January in the form of a booster dose for citizens above the age of 18.
28/12/2022
Bharat Biotech has said that its nasal vaccine against COVID-19, iNCOVACC, will be available to the public from the fourth week of January 2023.
The Hyderabad-based biotechnology company said the vaccine would cost Rs 800 for private markets and Rs 325 for governments.
Bharat Biotech’s INCOVACC is the world’s first intranasal COVID vaccine to receive approval for a primary 2-dose schedule as well as heterologous booster doses.
The nasal vaccine will be offered as a booster dose for those over the age of 18. iNCOVACC has been developed by Bharat Biotech in partnership with the University of Washington, USA.
